knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 12:18:30 - browse：525

Milken June 23 — Tina Reed, Paul Kluetz, John Oyler, and Solange Peters speak at the Milken Institute Future of Health Summit. Screen capture

The Covid-19 pandemic’s rapid spread across the world demanded a quick, collaborative response. Now, experts are asking how they can take the lessons from combating Covid-19 and apply them to diseases like cancer.

“As we look at Covid and the lessons we’re learning in the last year-and-a-half, it certainly is a lesson of successes and failures,” said John Oyler, CEO of BeiGene, in an event at the Milken Institute Future of Health Summit this week. “I strongly believe in oncology that we can and will learn from this set of experiences.”

The oncology community has already had to learn some of those lessons on the fly, as Covid-19 restrictions forced more patient care and clinical trials to be conducted remotely. Many researchers didn’t have the background or technology needed to carry out virtual assessments.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Wegovy, Zepbound and weight loss drugs that preserve muscle

WSS

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

AI generated plenty of interest at JPM but not a lot of trust

Dewpoint Therapeutics lays off staff after losing partnerships

Wegovy, Zepbound and weight loss drugs that preserve muscle

The surgeon had a dilemma only a Nazi medical text could resolve

FDA clears AI tool for detecting skin cancer

focus

knowledge

leisure time

Medicare details structure of new drug price negotiation program

Morphosys mixed study results for blood cancer drug

Guidelines to prevent youth baseball injuries need more muscle

NYU radiologists take on the challenge of expensive MRI machines

The high cost of giving birth even with insurance

Gain of function research would be limited under House proposal

Hepatitis C has a cure — but many Americans still lack access to it

World's first CRISPR

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Dewpoint Therapeutics lays off staff after losing partnerships

knowledge

The surgeon had a dilemma only a Nazi medical text could resolve

Humana cuts profit projections as Medicare Advantage costs soar

Elizabeth Holmes banned from government health programs

Anthos stroke drug appears safer than common blood thinner

How digital therapeutics firms are pivoting after Pear's bankruptcy

Morphosys mixed study results for blood cancer drug

entertainment

focus

hotspot

focus